SEARCH

SEARCH BY CITATION

References

  • 1
    Goldszmidt E, Kern R, Chaput A, Macarthur A. The incidence and etiology of postpartum headaches: A prospective cohort study. Can J Anaesth. 2005;52:971-977.
  • 2
    Stella CL, Jodicke CD, How HY, Harkness UF, Sibai BM. Postpartum headache: Is your work-up complete? Am J Obstet Gynecol. 2007;196:318 e1-318 e7.
  • 3
    Dodick DW. Pearls: Headache. Semin Neurol. 2010;30:74-81.
  • 4
    Bateman BT, Olbrecht VA, Berman MF, Minehart RD, Schwamm LH, Leffert LR. Peripartum subarachnoid hemorrhage: Nationwide data and institutional experience. Anesthesiology. 2012;116:324-333.
  • 5
    Tarshish S, Robbins MS. Teaching case presentation – primary thunderclap headache. Headache. 2009;49:1249-1250, discussion 50-2.
  • 6
    Society HCSotIH. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl. 1):9-160.
  • 7
    Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: A prospective cohort study. Cephalalgia. 2009;29:286-292.
  • 8
    Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: Frequency, features, and risk factors. Stroke. 2010;41:2505-2511.
  • 9
    Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 2004;61:411-416.
  • 10
    Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130(Pt 12):3091-3101.
  • 11
    Feske SK. Stroke in pregnancy. Semin Neurol. 2007;27:442-452.
  • 12
    Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med. 1996;335:768-774.
  • 13
    Roine S, Poyhonen M, Timonen S, et al. Neurologic symptoms are common during gestation and puerperium in CADASIL. Neurology. 2005;64:1441-1443.
  • 14
    Dodick DW, Wijdicks EF. Pituitary apoplexy presenting as a thunderclap headache. Neurology. 1998;50:1510-1511.
  • 15
    Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ. Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging. Am J Med. 1988;85:217-220.
  • 16
    Iuliano S, Laws ER Jr. Management of pituitary tumors in pregnancy. Semin Neurol. 2011;31:423-428.
  • 17
    Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women. Headache. 1993;33:385-389.
  • 18
    Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: A prospective study. Cephalalgia. 2003;23:197-205.
  • 19
    Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: A prospective study. Headache. 1997;37:203-210.
  • 20
    Hoshiyama E, Tatsumoto M, Iwanami H, et al. Postpartum migraines: A long-term prospective study. Intern Med. 2012;51:3119-3123.
  • 21
    Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: The MIGRA-study. J Headache Pain. 2011;12:443-451.
  • 22
    Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser M-G. CADASIL. Lancet Neurol. 2009;8:643-653.
  • 23
    Dong Y, Hassan A, Zhang A, Huber D, Dalageorgou C, Markus HS. Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke. 2003;34:203-206.
  • 24
    Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry. 2005;76:739-741.
  • 25
    Narayan SK, Gorman G, Kalaria RN, Ford GA, Chinnery PF. The minimum prevalence of CADASIL in northeast England. Neurology. 2012;78:1025-1027.
  • 26
    Joutel A, Dodick DD, Parisi JE, Cecillon M, Tournier-Lasserve E, Bousser M-G. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol. 2000;47:388-391.
  • 27
    Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases. Ann Neurol. 1998;44:731-739.
  • 28
    Desmond DW, Moroney JT, Lynch T, Chan S, Chin SS, Mohr JP. The natural history of CADASIL: A pooled analysis of previously published cases. Stroke. 1999;30:1230-1233.
  • 29
    Chabriat H, Vahedi K, Iba-Zizen MT, et al. Clinical spectrum of CADASIL: A study of 7 families. Lancet. 1995;346:934-939.
  • 30
    Gunda B, Herve D, Godin O, et al. Effects of gender on the phenotype of CADASIL. Stroke. 2012;43:137-141.
  • 31
    Roine S, Poyhonen M, Timonen S, et al. Neurologic symptoms are common during gestation and peurperium in CADASIL. Neurology. 2005;64:1441-1443.
  • 32
    Liem MK, Oberstein SA, van der Grond J, Ferrari MD, Haan J. CADASIL and migraine: A narrative review. Cephalalgia. 2010;30:1284-1289.
  • 33
    Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser M-G. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 2004;61:1237-1240.
  • 34
    Feuerhake F, Volk B, Ostertag CB, et al. Reversible coma with raised intracranial pressure: An unusual clinical manifestation of CADASIL. Acta Neuropathol. 2002;103:188-192.
  • 35
    Schon F, Martin RJ, Prevett M, Clough C, Enevoldson TP, Markus HS. “CADASIL coma”: An underdiagnosed acute encephalopathy. J Neurol Neurosurg Psychiatry. 2003;74:249-252.
  • 36
    Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects: Progression patterns and implications for clinical trials. Stroke. 2004;35:1603-1608.
  • 37
    Choi EJ, Choi CG, Kim JS. Large cerebral artery involvement in CADASIL. Neurology. 2005;65:1322-1324.
  • 38
    Bousser M-G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: From stroke to vessel wall physiology. J Neurol Neurosurg Psychiatry. 2001;70:285-287.
  • 39
    Buffon F, Porcher R, Hernandez K, et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry. 2006;77:175-180.
  • 40
    Reyes S, Viswanathan A, Godin O, et al. Apathy: A major symptom in CADASIL. Neurology. 2009;72:905-910.
  • 41
    Baudrimont M, Dubos F, Joutel A, Tournier-Lasserve E, Bousser M-G. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke: A clinicopathological study. Stroke. 1993;24:122-125.
  • 42
    Rinnoci V, Nannucci S, Valentin R, et al. Cerebral homorrhages in CADASIL: Report of four cases and a brief review. J Neurol Sci. 2013;330:45-51.
  • 43
    Dichgans M, Holtmannspotter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: A gradient-echo magnetic imaging and autopsy study. Stroke. 2002;33:67-71.
  • 44
    Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism Relat Disord. 2003;9:367-369.
  • 45
    Ragno M, Berbellini A, Cacchio G, et al. Parkinsonism is a late, not rare, feature of CADASIL: A study on Italian patients carrying the R1006C mutation. Stroke. 2013;44:1147-1149.
  • 46
    Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser M-G. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke. 1991;22:1297-1302.
  • 47
    Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology. 1998;51:452-457.
  • 48
    Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001;218:443-451.
  • 49
    O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensitives of the temporal lobe and external capsule in patients with CADASIL. Neurology. 2001;56:628-634.
  • 50
    Dichgans M, Wich M, Gasser T. Cerebrospinal fluid findings in CADASIL. Neurology. 1999;53:233.
  • 51
    Cumurciuc R, Massin P, Paques M, et al. Retinal abnormalities in CADASIL: A retrospective study of 18 patients. J Neurol Neurosurg Psychiatry. 2004;75:1058-1060.
  • 52
    Haritoglou C, Rudolph G, Hoops JP, Opherk C, Kampik A, Dichgans M. Retinal vascular abnormalities in CADASIL. Neurology. 2004;62:1202-1205.
  • 53
    Pretegiani E, Rosini F, Dotti MT, Bianchi S, Federico A, Rufa A. Visual system involvement in CADASIL. J Stroke Cerebrovasc Dis. 2013;22:1377-1384.
  • 54
    Lewandowska E, Dziewulska D, Parys M, Pasennik E. Ultrastructure of granular osmiophilic material deposits (GOM) in arterioles of CADASIL patients. Folia Neuropathol. 2011;49:174-180.
  • 55
    Lesnick Oberstein SA, van Duinen SG, van den Boom R, et al. Evaluation of diagnostic Notch 3 immunostaining in CADASIL. Acta Neuropathol. 2003;106:107-111.
  • 56
    Joutel A, Favrole P, Labauge P, et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet. 2001;358:2049-2051.
  • 57
    Donnini I, Nannucci S, Valenti R, et al. Acetazolamide for the prophyhlaxis of migraine in CADASIL: A preliminary experience. J Headache Pain. 2012;13:299-302.
  • 58
    Forteza AM, Brozman B, Rabinstein AA, Romano JG, Bradley WG. Acetazolamide for the treatment of migraine with aura in CADASIL. Neurology. 2001;57:2144-2145.
  • 59
    Weller M, Dichgans J, Klockgether T. Acetazolamide-responsive migraine in CADASIL. Neurology. 1998;50:1505.
  • 60
    Park SA, Yang CY, Choi SS, Kim WH. Assessment of cerebral hemodynamics to acetazolamide using brain perfusion SPECT in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Nucl Med. 2001;36:158-159.
  • 61
    Huang L, Yang Q, Zhang L, Chen X, Huang Q, Wang H. Acetazolamide improves cerebral hemodynamics in CADASIL. J Neurol Sci. 2010;292:77-80.
  • 62
    Choi JC, Kang SY, Kang JH, Park JK. Intracerebral hemorrhages in CADASIL. Neurology. 2006;67:2042-2044.
  • 63
    Dichgans M, Markus HS, Salloway S, et al. Donepezil in paitents with subcortical vascular cognitive impairment: A randomised double-blind trial in CADASIL. Lancet Neurol. 2008;7:310-318.